The Formulation Development Outsourcing Market was valued at USD 37.27 Billion in 2024, and is projected to reach USD 60.66 Billion by 2030, rising at a CAGR of 8.62%. The high burden of chronic and infectious diseases, the growing focus on improving the bioavailability of poorly soluble drugs, and the complications associated with drug development are contributing to the demand for formulation development services globally. Furthermore, the COVID-19 outbreak has influenced the need for clinical trials to find an effective treatment against the contagious virus. This has resulted in significant investments in research and development (R&D) to develop therapeutics, which are expected to drive the market.
According to Pharma R&D Annual Review 2022, biopharmaceutical and anticancer drugs are the major drugs in the development stage in the year 2022, this is expected to improve the demand for formulation development of these drugs post-pandemic. Globally, the pharmaceutical companies are making significant contributions to R&D activities. For instance, Merck’s R&D cost was USD 2.51 billion in 2020 as compared to USD 2.49 billion in 2019. Similarly, Biogen’s R&D expenses accounted for USD 3.99 billion in 2020. The company’s R&D expenditure increased by 75% as compared to 2019. The significant increase in R&D expenditure is likely to have a positive impact on the market.
A significant number of drugs fail to reach late-stage clinical trials owing to complications associated with formulation development. Moreover, strict regulations regarding the development of drugs are further contributing to the demand for outsourcing formulation development. Such factors are expected to improve the demand. The COVID-19 incidence has been significantly reduced owing to the growing vaccination drive globally. As a result, the CRO and CDMO are once again concentrating on the development of drugs for oncology and other disorders. For instance, in April 2022, Labcorp collaborated with Xcell Biosciences to support the company in developing cell and gene therapies for treating cancer, Parkinson’s disease, and other rare diseases. Such initiatives by the CDMOs are likely to promote the demand for the formulation development outsourcing of drugs used in the treatment of cancer and other rare diseases.
This product will be delivered within 1-3 business days.
According to Pharma R&D Annual Review 2022, biopharmaceutical and anticancer drugs are the major drugs in the development stage in the year 2022, this is expected to improve the demand for formulation development of these drugs post-pandemic. Globally, the pharmaceutical companies are making significant contributions to R&D activities. For instance, Merck’s R&D cost was USD 2.51 billion in 2020 as compared to USD 2.49 billion in 2019. Similarly, Biogen’s R&D expenses accounted for USD 3.99 billion in 2020. The company’s R&D expenditure increased by 75% as compared to 2019. The significant increase in R&D expenditure is likely to have a positive impact on the market.
A significant number of drugs fail to reach late-stage clinical trials owing to complications associated with formulation development. Moreover, strict regulations regarding the development of drugs are further contributing to the demand for outsourcing formulation development. Such factors are expected to improve the demand. The COVID-19 incidence has been significantly reduced owing to the growing vaccination drive globally. As a result, the CRO and CDMO are once again concentrating on the development of drugs for oncology and other disorders. For instance, in April 2022, Labcorp collaborated with Xcell Biosciences to support the company in developing cell and gene therapies for treating cancer, Parkinson’s disease, and other rare diseases. Such initiatives by the CDMOs are likely to promote the demand for the formulation development outsourcing of drugs used in the treatment of cancer and other rare diseases.
Formulation Development Outsourcing Market Report Highlights
- Based on services, the preformulation segment is expected to grow at the fastest CAGR during the forecast period.
- Based on formulation, the drug product segment is expected to grow at a significant CAGR during the forecast period.
- Based on therapeutic area, the oncology segment accounted for the largest market revenue share in 2024.
- Asia-Pacific held the largest revenue share in 2024, due to the presence of a significant number of CROs providing cost effective formulation development services.
Why Should You Buy This Report?
- Comprehensive Market Analysis: Gain detailed insights into the market across major regions and segments.
- Competitive Landscape: Explore the market presence of key players.
- Future Trends: Discover the pivotal trends and drivers shaping the future of the market.
- Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.
This report addresses:
- Market intelligence to enable effective decision-making
- Market estimates and forecasts from 2018 to 2030
- Growth opportunities and trend analyses
- Segment and regional revenue forecasts for market assessment
- Competition strategy and market share analysis
- Product innovation listings for you to stay ahead of the curve
This product will be delivered within 1-3 business days.
Table of Contents
Chapter 1. Research Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Service
1.2.2. Formulation
1.2.3. Therapeutic Area
1.2.4. End Use
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased Database
1.4.2. Internal Database
1.4.3. Secondary Sources
1.4.4. Primary Research
1.5. Information or Data Analysis
1.5.1. Data Analysis Models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity Flow Analysis
1.7.2. Parent Market Analysis
1.8. List of Secondary Sources
1.9. List of Abbreviations
1.10. Objectives
1.2. Segment Definitions
1.2.1. Service
1.2.2. Formulation
1.2.3. Therapeutic Area
1.2.4. End Use
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased Database
1.4.2. Internal Database
1.4.3. Secondary Sources
1.4.4. Primary Research
1.5. Information or Data Analysis
1.5.1. Data Analysis Models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity Flow Analysis
1.7.2. Parent Market Analysis
1.8. List of Secondary Sources
1.9. List of Abbreviations
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. Formulation Development Outsourcing Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.2. Market Restraint Analysis
3.3. Clinical Trials Volume Analysis, (2024)
3.3.1. Total Number of Clinical Trials by Region
3.3.2. Total Number of Clinical Trials, by Phase
3.3.3. Total Number of Clinical Trials, by Study Design
3.3.4. Total Number of Clinical Trials, by Key Therapeutic Area
3.4. Pricing Model Analysis
3.5. Technology Landscape
3.6. Market Analysis Tools
3.6.1. Porter’s Five Force Analysis
3.6.2. PESTEL by SWOT Analysis
3.6.3. COVID-19 Impact Analysis
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.2. Market Restraint Analysis
3.3. Clinical Trials Volume Analysis, (2024)
3.3.1. Total Number of Clinical Trials by Region
3.3.2. Total Number of Clinical Trials, by Phase
3.3.3. Total Number of Clinical Trials, by Study Design
3.3.4. Total Number of Clinical Trials, by Key Therapeutic Area
3.4. Pricing Model Analysis
3.5. Technology Landscape
3.6. Market Analysis Tools
3.6.1. Porter’s Five Force Analysis
3.6.2. PESTEL by SWOT Analysis
3.6.3. COVID-19 Impact Analysis
Chapter 4. Formulation Development Outsourcing Market: Service Estimates & Trend Analysis
4.1. Formulation Development Outsourcing Market, by Service: Segment Dashboard
4.2. Formulation Development Outsourcing Market, by Service: Movement Analysis
4.3. Formulation Development Outsourcing Market Estimates & Forecasts, by Service, 2018-2030
4.4. Preformulation
4.4.1. Preformulation Market Estimates and Forecasts, 2018-2030 (USD Million)
4.5. Formulation Development
4.5.1. Formulation Development Market Estimates and Forecasts, 2018-2030 (USD Million)
4.2. Formulation Development Outsourcing Market, by Service: Movement Analysis
4.3. Formulation Development Outsourcing Market Estimates & Forecasts, by Service, 2018-2030
4.4. Preformulation
4.4.1. Preformulation Market Estimates and Forecasts, 2018-2030 (USD Million)
4.5. Formulation Development
4.5.1. Formulation Development Market Estimates and Forecasts, 2018-2030 (USD Million)
Chapter 5. Formulation Development Outsourcing Market: Formulation Estimates & Trend Analysis
5.1. Formulation Development Outsourcing Market, by Formulation: Segment Dashboard
5.2. Formulation Development Outsourcing Market, by Formulation: Movement Analysis
5.3. Formulation Development Outsourcing Market Estimates & Forecasts, by Formulation, 2018-2030
5.4. Oral
5.4.1. Oral Market Estimates and Forecasts, 2018-2030 (USD Million)
5.5. Injectable
5.5.1. Injectable Market Estimates and Forecasts, 2018-2030 (USD Million)
5.6. Topical
5.6.1. Topical Market Estimates and Forecasts, 2018-2030 (USD Million)
5.7. Others
5.7.1. Others Market Estimates and Forecasts, 2018-2030 (USD Million)
5.2. Formulation Development Outsourcing Market, by Formulation: Movement Analysis
5.3. Formulation Development Outsourcing Market Estimates & Forecasts, by Formulation, 2018-2030
5.4. Oral
5.4.1. Oral Market Estimates and Forecasts, 2018-2030 (USD Million)
5.5. Injectable
5.5.1. Injectable Market Estimates and Forecasts, 2018-2030 (USD Million)
5.6. Topical
5.6.1. Topical Market Estimates and Forecasts, 2018-2030 (USD Million)
5.7. Others
5.7.1. Others Market Estimates and Forecasts, 2018-2030 (USD Million)
Chapter 6. Formulation Development Outsourcing Market: Therapeutic Area Estimates & Trend Analysis
6.1. Formulation Development Outsourcing Market, by Therapeutic Area: Segment Dashboard
6.2. Formulation Development Outsourcing Market, by Therapeutic Area: Movement Analysis
6.3. Formulation Development Outsourcing Market Estimates & Forecasts, by Therapeutic Area, 2018-2030
6.4. Oncology
6.4.1. Oncology Market Estimates and Forecasts, 2018-2030 (USD Million)
6.5. Infectious Disease
6.5.1. Infectious Disease Market Estimates and Forecasts, 2018-2030 (USD Million)
6.6. Neurology
6.6.1. Neurology Market Estimates and Forecasts, 2018-2030 (USD Million)
6.7. Hematology
6.7.1. Hematology Market Estimates and Forecasts, 2018-2030 (USD Million)
6.8. Respiratory
6.8.1. Respiratory Market Estimates and Forecasts, 2018-2030 (USD Million)
6.9. Cardiovascular
6.9.1. Cardiovascular Market Estimates and Forecasts, 2018-2030 (USD Million)
6.10. Dermatology
6.10.1. Dermatology Market Estimates and Forecasts, 2018-2030 (USD Million)
6.11. Others
6.11.1. Others Market Estimates and Forecasts, 2018-2030 (USD Million)
6.2. Formulation Development Outsourcing Market, by Therapeutic Area: Movement Analysis
6.3. Formulation Development Outsourcing Market Estimates & Forecasts, by Therapeutic Area, 2018-2030
6.4. Oncology
6.4.1. Oncology Market Estimates and Forecasts, 2018-2030 (USD Million)
6.5. Infectious Disease
6.5.1. Infectious Disease Market Estimates and Forecasts, 2018-2030 (USD Million)
6.6. Neurology
6.6.1. Neurology Market Estimates and Forecasts, 2018-2030 (USD Million)
6.7. Hematology
6.7.1. Hematology Market Estimates and Forecasts, 2018-2030 (USD Million)
6.8. Respiratory
6.8.1. Respiratory Market Estimates and Forecasts, 2018-2030 (USD Million)
6.9. Cardiovascular
6.9.1. Cardiovascular Market Estimates and Forecasts, 2018-2030 (USD Million)
6.10. Dermatology
6.10.1. Dermatology Market Estimates and Forecasts, 2018-2030 (USD Million)
6.11. Others
6.11.1. Others Market Estimates and Forecasts, 2018-2030 (USD Million)
Chapter 7. Formulation Development Outsourcing Market: End Use Estimates & Trend Analysis
7.1. Formulation Development Outsourcing Market, by End Use: Segment Dashboard
7.2. Formulation Development Outsourcing Market, by End Use: Movement Analysis
7.3. Formulation Development Outsourcing Market Estimates & Forecasts, by End Use, 2018-2030
7.4. Pharmaceutical and Biopharmaceutical Companies
7.4.1. Pharmaceutical and Biopharmaceutical Companies Market Estimates and Forecasts, 2018-2030 (USD Million)
7.5. Government and Academic Institutes
7.5.1. Government and Academic Institutes Market Estimates and Forecasts, 2018-2030 (USD Million)
7.6. Others
7.6.1. Others Market Estimates and Forecasts, 2018-2030 (USD Million)
7.2. Formulation Development Outsourcing Market, by End Use: Movement Analysis
7.3. Formulation Development Outsourcing Market Estimates & Forecasts, by End Use, 2018-2030
7.4. Pharmaceutical and Biopharmaceutical Companies
7.4.1. Pharmaceutical and Biopharmaceutical Companies Market Estimates and Forecasts, 2018-2030 (USD Million)
7.5. Government and Academic Institutes
7.5.1. Government and Academic Institutes Market Estimates and Forecasts, 2018-2030 (USD Million)
7.6. Others
7.6.1. Others Market Estimates and Forecasts, 2018-2030 (USD Million)
Chapter 8. Formulation Development Outsourcing Market: Regional Estimates & Trend Analysis
8.1. Regional Market Share Analysis, 2024 & 2030
8.2. Regional Market Dashboard
8.3. Global Regional Market Snapshot
8.4. North America
8.4.1. North America Market Estimates and Forecasts, 2018-2030 (USD Million)
8.4.2. U.S
8.4.2.1. Key Country Dynamics
8.4.2.2. Competitive Scenario
8.4.2.3. Regulatory Framework
8.4.2.4. U.S. Market Estimates and Forecasts, 2018-2030 (USD Million)
8.4.3. Canada
8.4.3.1. Key Country Dynamics
8.4.3.2. Competitive Scenario
8.4.3.3. Regulatory Framework
8.4.3.4. Canada Market Estimates and Forecasts, 2018-2030 (USD Million)
8.4.4. Mexico
8.4.4.1. Key Country Dynamics
8.4.4.2. Competitive Scenario
8.4.4.3. Regulatory Framework
8.4.4.4. Mexico Market Estimates and Forecasts, 2018-2030 (USD Million)
8.5. Europe
8.5.1. Europe Market Estimates and Forecasts, 2018-2030 (USD Million)
8.5.2. UK
8.5.2.1. Key Country Dynamics
8.5.2.2. Competitive Scenario
8.5.2.3. Regulatory Framework
8.5.2.4. UK Market Estimates and Forecasts, 2018-2030 (USD Million)
8.5.3. Germany
8.5.3.1. Key Country Dynamics
8.5.3.2. Competitive Scenario
8.5.3.3. Regulatory Framework
8.5.3.4. Germany Market Estimates and Forecasts, 2018-2030 (USD Million)
8.5.4. France
8.5.4.1. Key Country Dynamics
8.5.4.2. Competitive Scenario
8.5.4.3. Regulatory Framework
8.5.4.4. France Market Estimates and Forecasts, 2018-2030 (USD Million)
8.5.5. Italy
8.5.5.1. Key Country Dynamics
8.5.5.2. Competitive Scenario
8.5.5.3. Regulatory Framework
8.5.5.4. Italy Market Estimates and Forecasts, 2018-2030 (USD Million)
8.5.6. Spain
8.5.6.1. Key Country Dynamics
8.5.6.2. Competitive Scenario
8.5.6.3. Regulatory Framework
8.5.6.4. Spain Market Estimates and Forecasts, 2018-2030 (USD Million)
8.5.7. Netherlands
8.5.7.1. Key Country Dynamics
8.5.7.2. Competitive Scenario
8.5.7.3. Regulatory Framework
8.5.7.4. Netherlands Market Estimates and Forecasts, 2018-2030 (USD Million)
8.5.8. Switzerland
8.5.8.1. Key Country Dynamics
8.5.8.2. Competitive Scenario
8.5.8.3. Regulatory Framework
8.5.8.4. Switzerland Market Estimates and Forecasts, 2018-2030 (USD Million)
8.5.9. Sweden
8.5.9.1. Key Country Dynamics
8.5.9.2. Competitive Scenario
8.5.9.3. Regulatory Framework
8.5.9.4. Sweden Market Estimates and Forecasts, 2018-2030 (USD Million)
8.5.10. Denmark
8.5.10.1. Key Country Dynamics
8.5.10.2. Competitive Scenario
8.5.10.3. Regulatory Framework
8.5.10.4. Denmark Market Estimates and Forecasts, 2018-2030 (USD Million)
8.5.11. Norway
8.5.11.1. Key Country Dynamics
8.5.11.2. Competitive Scenario
8.5.11.3. Regulatory Framework
8.5.11.4. Norway Market Estimates and Forecasts, 2018-2030 (USD Million)
8.6. Asia Pacific
8.6.1. Asia Pacific Market Estimates and Forecasts, 2018-2030 (USD Million)
8.6.2. China
8.6.2.1. Key Country Dynamics
8.6.2.2. Competitive Scenario
8.6.2.3. Regulatory Framework
8.6.2.4. China Market Estimates and Forecasts, 2018-2030 (USD Million)
8.6.3. India
8.6.3.1. Key Country Dynamics
8.6.3.2. Competitive Scenario
8.6.3.3. Regulatory Framework
8.6.3.4. India Market Estimates and Forecasts, 2018-2030 (USD Million)
8.6.4. Japan
8.6.4.1. Key Country Dynamics
8.6.4.2. Competitive Scenario
8.6.4.3. Regulatory Framework
8.6.4.4. Japan Market Estimates and Forecasts, 2018-2030 (USD Million)
8.6.5. Australia
8.6.5.1. Key Country Dynamics
8.6.5.2. Competitive Scenario
8.6.5.3. Regulatory Framework
8.6.5.4. Australia Market Estimates and Forecasts, 2018-2030 (USD Million)
8.6.6. South Korea
8.6.6.1. Key Country Dynamics
8.6.6.2. Competitive Scenario
8.6.6.3. Regulatory Framework
8.6.6.4. South Korea Market Estimates and Forecasts, 2018-2030 (USD Million)
8.6.7. Indonesia
8.6.7.1. Key Country Dynamics
8.6.7.2. Competitive Scenario
8.6.7.3. Regulatory Framework
8.6.7.4. Indonesia Market Estimates and Forecasts, 2018-2030 (USD Million)
8.6.8. Malaysia
8.6.8.1. Key Country Dynamics
8.6.8.2. Competitive Scenario
8.6.8.3. Regulatory Framework
8.6.8.4. Malaysia Market Estimates and Forecasts, 2018-2030 (USD Million)
8.6.9. Singapore
8.6.9.1. Key Country Dynamics
8.6.9.2. Competitive Scenario
8.6.9.3. Regulatory Framework
8.6.9.4. Singapore Market Estimates and Forecasts, 2018-2030 (USD Million)
8.6.10. Thailand
8.6.10.1. Key Country Dynamics
8.6.10.2. Competitive Scenario
8.6.10.3. Regulatory Framework
8.6.10.4. Thailand Market Estimates and Forecasts, 2018-2030 (USD Million)
8.6.11. Taiwan
8.6.11.1. Key Country Dynamics
8.6.11.2. Competitive Scenario
8.6.11.3. Regulatory Framework
8.6.11.4. Taiwan Market Estimates and Forecasts, 2018-2030 (USD Million)
8.7. Latin America
8.7.1. Latin America Market Estimates and Forecasts, 2018-2030 (USD Million)
8.7.2. Brazil
8.7.2.1. Key Country Dynamics
8.7.2.2. Competitive Scenario
8.7.2.3. Regulatory Framework
8.7.2.4. Brazil Market Estimates and Forecasts, 2018-2030 (USD Million)
8.7.3. Argentina
8.7.3.1. Key Country Dynamics
8.7.3.2. Competitive Scenario
8.7.3.3. Regulatory Framework
8.7.3.4. Argentina Market Estimates and Forecasts, 2018-2030 (USD Million)
8.7.4. Colombia
8.7.4.1. Key Country Dynamics
8.7.4.2. Competitive Scenario
8.7.4.3. Regulatory Framework
8.7.4.4. Colombia Market Estimates and Forecasts, 2018-2030 (USD Million)
8.7.5. Chile
8.7.5.1. Key Country Dynamics
8.7.5.2. Competitive Scenario
8.7.5.3. Regulatory Framework
8.7.5.4. Chile Market Estimates and Forecasts, 2018-2030 (USD Million)
8.8. MEA
8.8.1. MEA Market Estimates and Forecasts, 2018-2030 (USD Million)
8.8.2. South Africa
8.8.2.1. Key Country Dynamics
8.8.2.2. Competitive Scenario
8.8.2.3. Regulatory Framework
8.8.2.4. South Africa Market Estimates and Forecasts, 2018-2030 (USD Million)
8.8.3. Saudi Arabia
8.8.3.1. Key Country Dynamics
8.8.3.2. Competitive Scenario
8.8.3.3. Regulatory Framework
8.8.3.4. Saudi Arabia Market Estimates and Forecasts, 2018-2030 (USD Million)
8.8.4. UAE
8.8.4.1. Key Country Dynamics
8.8.4.2. Competitive Scenario
8.8.4.3. Regulatory Framework
8.8.4.4. UAE Market Estimates and Forecasts, 2018-2030 (USD Million)
8.8.5. Egypt
8.8.5.1. Key Country Dynamics
8.8.5.2. Competitive Scenario
8.8.5.3. Regulatory Framework
8.8.5.4. Egypt Market Estimates and Forecasts, 2018-2030 (USD Million)
8.8.6. Israel
8.8.6.1. Key Country Dynamics
8.8.6.2. Competitive Scenario
8.8.6.3. Regulatory Framework
8.8.6.4. Israel Market Estimates and Forecasts, 2018-2030 (USD Million)
8.8.7. Kuwait
8.8.7.1. Key Country Dynamics
8.8.7.2. Competitive Scenario
8.8.7.3. Regulatory Framework
8.8.7.4. Kuwait Market Estimates and Forecasts, 2018-2030 (USD Million)
8.2. Regional Market Dashboard
8.3. Global Regional Market Snapshot
8.4. North America
8.4.1. North America Market Estimates and Forecasts, 2018-2030 (USD Million)
8.4.2. U.S
8.4.2.1. Key Country Dynamics
8.4.2.2. Competitive Scenario
8.4.2.3. Regulatory Framework
8.4.2.4. U.S. Market Estimates and Forecasts, 2018-2030 (USD Million)
8.4.3. Canada
8.4.3.1. Key Country Dynamics
8.4.3.2. Competitive Scenario
8.4.3.3. Regulatory Framework
8.4.3.4. Canada Market Estimates and Forecasts, 2018-2030 (USD Million)
8.4.4. Mexico
8.4.4.1. Key Country Dynamics
8.4.4.2. Competitive Scenario
8.4.4.3. Regulatory Framework
8.4.4.4. Mexico Market Estimates and Forecasts, 2018-2030 (USD Million)
8.5. Europe
8.5.1. Europe Market Estimates and Forecasts, 2018-2030 (USD Million)
8.5.2. UK
8.5.2.1. Key Country Dynamics
8.5.2.2. Competitive Scenario
8.5.2.3. Regulatory Framework
8.5.2.4. UK Market Estimates and Forecasts, 2018-2030 (USD Million)
8.5.3. Germany
8.5.3.1. Key Country Dynamics
8.5.3.2. Competitive Scenario
8.5.3.3. Regulatory Framework
8.5.3.4. Germany Market Estimates and Forecasts, 2018-2030 (USD Million)
8.5.4. France
8.5.4.1. Key Country Dynamics
8.5.4.2. Competitive Scenario
8.5.4.3. Regulatory Framework
8.5.4.4. France Market Estimates and Forecasts, 2018-2030 (USD Million)
8.5.5. Italy
8.5.5.1. Key Country Dynamics
8.5.5.2. Competitive Scenario
8.5.5.3. Regulatory Framework
8.5.5.4. Italy Market Estimates and Forecasts, 2018-2030 (USD Million)
8.5.6. Spain
8.5.6.1. Key Country Dynamics
8.5.6.2. Competitive Scenario
8.5.6.3. Regulatory Framework
8.5.6.4. Spain Market Estimates and Forecasts, 2018-2030 (USD Million)
8.5.7. Netherlands
8.5.7.1. Key Country Dynamics
8.5.7.2. Competitive Scenario
8.5.7.3. Regulatory Framework
8.5.7.4. Netherlands Market Estimates and Forecasts, 2018-2030 (USD Million)
8.5.8. Switzerland
8.5.8.1. Key Country Dynamics
8.5.8.2. Competitive Scenario
8.5.8.3. Regulatory Framework
8.5.8.4. Switzerland Market Estimates and Forecasts, 2018-2030 (USD Million)
8.5.9. Sweden
8.5.9.1. Key Country Dynamics
8.5.9.2. Competitive Scenario
8.5.9.3. Regulatory Framework
8.5.9.4. Sweden Market Estimates and Forecasts, 2018-2030 (USD Million)
8.5.10. Denmark
8.5.10.1. Key Country Dynamics
8.5.10.2. Competitive Scenario
8.5.10.3. Regulatory Framework
8.5.10.4. Denmark Market Estimates and Forecasts, 2018-2030 (USD Million)
8.5.11. Norway
8.5.11.1. Key Country Dynamics
8.5.11.2. Competitive Scenario
8.5.11.3. Regulatory Framework
8.5.11.4. Norway Market Estimates and Forecasts, 2018-2030 (USD Million)
8.6. Asia Pacific
8.6.1. Asia Pacific Market Estimates and Forecasts, 2018-2030 (USD Million)
8.6.2. China
8.6.2.1. Key Country Dynamics
8.6.2.2. Competitive Scenario
8.6.2.3. Regulatory Framework
8.6.2.4. China Market Estimates and Forecasts, 2018-2030 (USD Million)
8.6.3. India
8.6.3.1. Key Country Dynamics
8.6.3.2. Competitive Scenario
8.6.3.3. Regulatory Framework
8.6.3.4. India Market Estimates and Forecasts, 2018-2030 (USD Million)
8.6.4. Japan
8.6.4.1. Key Country Dynamics
8.6.4.2. Competitive Scenario
8.6.4.3. Regulatory Framework
8.6.4.4. Japan Market Estimates and Forecasts, 2018-2030 (USD Million)
8.6.5. Australia
8.6.5.1. Key Country Dynamics
8.6.5.2. Competitive Scenario
8.6.5.3. Regulatory Framework
8.6.5.4. Australia Market Estimates and Forecasts, 2018-2030 (USD Million)
8.6.6. South Korea
8.6.6.1. Key Country Dynamics
8.6.6.2. Competitive Scenario
8.6.6.3. Regulatory Framework
8.6.6.4. South Korea Market Estimates and Forecasts, 2018-2030 (USD Million)
8.6.7. Indonesia
8.6.7.1. Key Country Dynamics
8.6.7.2. Competitive Scenario
8.6.7.3. Regulatory Framework
8.6.7.4. Indonesia Market Estimates and Forecasts, 2018-2030 (USD Million)
8.6.8. Malaysia
8.6.8.1. Key Country Dynamics
8.6.8.2. Competitive Scenario
8.6.8.3. Regulatory Framework
8.6.8.4. Malaysia Market Estimates and Forecasts, 2018-2030 (USD Million)
8.6.9. Singapore
8.6.9.1. Key Country Dynamics
8.6.9.2. Competitive Scenario
8.6.9.3. Regulatory Framework
8.6.9.4. Singapore Market Estimates and Forecasts, 2018-2030 (USD Million)
8.6.10. Thailand
8.6.10.1. Key Country Dynamics
8.6.10.2. Competitive Scenario
8.6.10.3. Regulatory Framework
8.6.10.4. Thailand Market Estimates and Forecasts, 2018-2030 (USD Million)
8.6.11. Taiwan
8.6.11.1. Key Country Dynamics
8.6.11.2. Competitive Scenario
8.6.11.3. Regulatory Framework
8.6.11.4. Taiwan Market Estimates and Forecasts, 2018-2030 (USD Million)
8.7. Latin America
8.7.1. Latin America Market Estimates and Forecasts, 2018-2030 (USD Million)
8.7.2. Brazil
8.7.2.1. Key Country Dynamics
8.7.2.2. Competitive Scenario
8.7.2.3. Regulatory Framework
8.7.2.4. Brazil Market Estimates and Forecasts, 2018-2030 (USD Million)
8.7.3. Argentina
8.7.3.1. Key Country Dynamics
8.7.3.2. Competitive Scenario
8.7.3.3. Regulatory Framework
8.7.3.4. Argentina Market Estimates and Forecasts, 2018-2030 (USD Million)
8.7.4. Colombia
8.7.4.1. Key Country Dynamics
8.7.4.2. Competitive Scenario
8.7.4.3. Regulatory Framework
8.7.4.4. Colombia Market Estimates and Forecasts, 2018-2030 (USD Million)
8.7.5. Chile
8.7.5.1. Key Country Dynamics
8.7.5.2. Competitive Scenario
8.7.5.3. Regulatory Framework
8.7.5.4. Chile Market Estimates and Forecasts, 2018-2030 (USD Million)
8.8. MEA
8.8.1. MEA Market Estimates and Forecasts, 2018-2030 (USD Million)
8.8.2. South Africa
8.8.2.1. Key Country Dynamics
8.8.2.2. Competitive Scenario
8.8.2.3. Regulatory Framework
8.8.2.4. South Africa Market Estimates and Forecasts, 2018-2030 (USD Million)
8.8.3. Saudi Arabia
8.8.3.1. Key Country Dynamics
8.8.3.2. Competitive Scenario
8.8.3.3. Regulatory Framework
8.8.3.4. Saudi Arabia Market Estimates and Forecasts, 2018-2030 (USD Million)
8.8.4. UAE
8.8.4.1. Key Country Dynamics
8.8.4.2. Competitive Scenario
8.8.4.3. Regulatory Framework
8.8.4.4. UAE Market Estimates and Forecasts, 2018-2030 (USD Million)
8.8.5. Egypt
8.8.5.1. Key Country Dynamics
8.8.5.2. Competitive Scenario
8.8.5.3. Regulatory Framework
8.8.5.4. Egypt Market Estimates and Forecasts, 2018-2030 (USD Million)
8.8.6. Israel
8.8.6.1. Key Country Dynamics
8.8.6.2. Competitive Scenario
8.8.6.3. Regulatory Framework
8.8.6.4. Israel Market Estimates and Forecasts, 2018-2030 (USD Million)
8.8.7. Kuwait
8.8.7.1. Key Country Dynamics
8.8.7.2. Competitive Scenario
8.8.7.3. Regulatory Framework
8.8.7.4. Kuwait Market Estimates and Forecasts, 2018-2030 (USD Million)
Chapter 9. Competitive Landscape
9.1. Market Participant Categorization
9.2. Company Market Share/Assessment Analysis, 2024
9.3. Company Profiles
9.3.1. SGS S.A.
9.3.1.1. Company Overview
9.3.1.2. Financial Performance
9.3.1.3. Service Benchmarking
9.3.1.4. Strategic Initiatives
9.3.2. Intertek Group plc
9.3.2.1. Company Overview
9.3.2.2. Financial Performance
9.3.2.3. Service Benchmarking
9.3.2.4. Strategic Initiatives
9.3.3. Recipharm
9.3.3.1. Company Overview
9.3.3.2. Financial Performance
9.3.3.3. Service Benchmarking
9.3.3.4. Strategic Initiatives
9.3.4. Lonza
9.3.4.1. Company Overview
9.3.4.2. Financial Performance
9.3.4.3. Service Benchmarking
9.3.4.4. Strategic Initiatives
9.3.5. Charles River Laboratories International, Inc.
9.3.5.1. Company Overview
9.3.5.2. Financial Performance
9.3.5.3. Service Benchmarking
9.3.5.4. Strategic Initiatives
9.3.6. Eurofins Scientific SE
9.3.6.1. Company Overview
9.3.6.2. Financial Performance
9.3.6.3. Service Benchmarking
9.3.6.4. Strategic Initiatives
9.3.7. Element
9.3.7.1. Company Overview
9.3.7.2. Financial Performance
9.3.7.3. Service Benchmarking
9.3.7.4. Strategic Initiatives
9.3.8. Labcorp
9.3.8.1. Company Overview
9.3.8.2. Financial Performance
9.3.8.3. Service Benchmarking
9.3.8.4. Strategic Initiatives
9.3.9. Thermo Fisher Scientific, Inc.
9.3.9.1. Company Overview
9.3.9.2. Financial Performance
9.3.9.3. Service Benchmarking
9.3.9.4. Strategic Initiatives
9.3.10. Catalent Inc.
9.3.10.1. Company Overview
9.3.10.2. Financial Performance
9.3.10.3. Service Benchmarking
9.3.10.4. Strategic Initiatives
9.2. Company Market Share/Assessment Analysis, 2024
9.3. Company Profiles
9.3.1. SGS S.A.
9.3.1.1. Company Overview
9.3.1.2. Financial Performance
9.3.1.3. Service Benchmarking
9.3.1.4. Strategic Initiatives
9.3.2. Intertek Group plc
9.3.2.1. Company Overview
9.3.2.2. Financial Performance
9.3.2.3. Service Benchmarking
9.3.2.4. Strategic Initiatives
9.3.3. Recipharm
9.3.3.1. Company Overview
9.3.3.2. Financial Performance
9.3.3.3. Service Benchmarking
9.3.3.4. Strategic Initiatives
9.3.4. Lonza
9.3.4.1. Company Overview
9.3.4.2. Financial Performance
9.3.4.3. Service Benchmarking
9.3.4.4. Strategic Initiatives
9.3.5. Charles River Laboratories International, Inc.
9.3.5.1. Company Overview
9.3.5.2. Financial Performance
9.3.5.3. Service Benchmarking
9.3.5.4. Strategic Initiatives
9.3.6. Eurofins Scientific SE
9.3.6.1. Company Overview
9.3.6.2. Financial Performance
9.3.6.3. Service Benchmarking
9.3.6.4. Strategic Initiatives
9.3.7. Element
9.3.7.1. Company Overview
9.3.7.2. Financial Performance
9.3.7.3. Service Benchmarking
9.3.7.4. Strategic Initiatives
9.3.8. Labcorp
9.3.8.1. Company Overview
9.3.8.2. Financial Performance
9.3.8.3. Service Benchmarking
9.3.8.4. Strategic Initiatives
9.3.9. Thermo Fisher Scientific, Inc.
9.3.9.1. Company Overview
9.3.9.2. Financial Performance
9.3.9.3. Service Benchmarking
9.3.9.4. Strategic Initiatives
9.3.10. Catalent Inc.
9.3.10.1. Company Overview
9.3.10.2. Financial Performance
9.3.10.3. Service Benchmarking
9.3.10.4. Strategic Initiatives
List of Tables
Table 1 List of Secondary Sources
Table 2 List of Abbreviations
Table 3 Global Formulation Development Outsourcing Market Estimates and Forecasts, by Service, 2018-2030 (USD Million)
Table 4 Global Formulation Development Outsourcing Market Estimates and Forecasts, by Formulation, 2018-2030 (USD Million)
Table 5 Global Formulation Development Outsourcing Market Estimates and Forecasts, by Therapeutic Area, 2018-2030 (USD Million)
Table 6 Global Formulation Development Outsourcing Market Estimates and Forecasts, by End Use, 2018-2030 (USD Million)
Table 7 Global Formulation Development Outsourcing Market Estimates and Forecasts, by Region, 2018-2030 (USD Million)
Table 8 North America Formulation Development Outsourcing Market Estimates and Forecasts, by Country, 2018-2030 (USD Million)
Table 9 North America Formulation Development Outsourcing Market Estimates and Forecasts, by Service, 2018-2030 (USD Million)
Table 10 North America Formulation Development Outsourcing Market Estimates and Forecasts, by Formulation, 2018-2030 (USD Million)
Table 11 North America Formulation Development Outsourcing Market Estimates and Forecasts, by Therapeutic Area, 2018-2030 (USD Million)
Table 12 North America Formulation Development Outsourcing Market Estimates and Forecasts, by End Use, 2018-2030 (USD Million)
Table 13 U.S. Formulation Development Outsourcing Market Estimates and Forecasts, by Service, 2018-2030 (USD Million)
Table 14 U.S. Formulation Development Outsourcing Market Estimates and Forecasts, by Formulation, 2018-2030 (USD Million)
Table 15 U.S. Formulation Development Outsourcing Market Estimates and Forecasts, by Therapeutic Area, 2018-2030 (USD Million)
Table 16 U.S. Formulation Development Outsourcing Market Estimates and Forecasts, by End Use, 2018-2030 (USD Million)
Table 17 Canada Formulation Development Outsourcing Market Estimates and Forecasts, by Service, 2018-2030 (USD Million)
Table 18 Canada Formulation Development Outsourcing Market Estimates and Forecasts, by Formulation, 2018-2030 (USD Million)
Table 19 Canada Formulation Development Outsourcing Market Estimates and Forecasts, by Therapeutic Area, 2018-2030 (USD Million)
Table 20 Canada Formulation Development Outsourcing Market Estimates and Forecasts, by End Use, 2018-2030 (USD Million)
Table 21 Mexico Formulation Development Outsourcing Market Estimates and Forecasts, by Service, 2018-2030 (USD Million)
Table 22 Mexico Formulation Development Outsourcing Market Estimates and Forecasts, by Formulation, 2018-2030 (USD Million)
Table 23 Mexico Formulation Development Outsourcing Market Estimates and Forecasts, by Therapeutic Area, 2018-2030 (USD Million)
Table 24 Mexico Formulation Development Outsourcing Market Estimates and Forecasts, by End Use, 2018-2030 (USD Million)
Table 25 Europe Formulation Development Outsourcing Market Estimates and Forecasts, by Country, 2018-2030 (USD Million)
Table 26 Europe Formulation Development Outsourcing Market Estimates and Forecasts, by Service, 2018-2030 (USD Million)
Table 27 Europe Formulation Development Outsourcing Market Estimates and Forecasts, by Formulation, 2018-2030 (USD Million)
Table 28 Europe Formulation Development Outsourcing Market Estimates and Forecasts, by Therapeutic Area, 2018-2030 (USD Million)
Table 29 Europe Formulation Development Outsourcing Market Estimates and Forecasts, by End Use, 2018-2030 (USD Million)
Table 30 UK Formulation Development Outsourcing Market Estimates and Forecasts, by Service, 2018-2030 (USD Million)
Table 31 UK Formulation Development Outsourcing Market Estimates and Forecasts, by Formulation, 2018-2030 (USD Million)
Table 32 UK Formulation Development Outsourcing Market Estimates and Forecasts, by Therapeutic Area, 2018-2030 (USD Million)
Table 33 UK Formulation Development Outsourcing Market Estimates and Forecasts, by End Use, 2018-2030 (USD Million)
Table 34 Germany Formulation Development Outsourcing Market Estimates and Forecasts, by Service, 2018-2030 (USD Million)
Table 35 Germany Formulation Development Outsourcing Market Estimates and Forecasts, by Formulation, 2018-2030 (USD Million)
Table 36 Germany Formulation Development Outsourcing Market Estimates and Forecasts, by Therapeutic Area, 2018-2030 (USD Million)
Table 37 Germany Formulation Development Outsourcing Market Estimates and Forecasts, by End Use, 2018-2030 (USD Million)
Table 38 France Formulation Development Outsourcing Market Estimates and Forecasts, by Service, 2018-2030 (USD Million)
Table 39 France Formulation Development Outsourcing Market Estimates and Forecasts, by Formulation, 2018-2030 (USD Million)
Table 40 France Formulation Development Outsourcing Market Estimates and Forecasts, by Therapeutic Area, 2018-2030 (USD Million)
Table 41 France Formulation Development Outsourcing Market Estimates and Forecasts, by End Use, 2018-2030 (USD Million)
Table 42 Italy Formulation Development Outsourcing Market Estimates and Forecasts, by Service, 2018-2030 (USD Million)
Table 43 Italy Formulation Development Outsourcing Market Estimates and Forecasts, by Formulation, 2018-2030 (USD Million)
Table 44 Italy Formulation Development Outsourcing Market Estimates and Forecasts, by Therapeutic Area, 2018-2030 (USD Million)
Table 45 Italy Formulation Development Outsourcing Market Estimates and Forecasts, by End Use, 2018-2030 (USD Million)
Table 46 Spain Formulation Development Outsourcing Market Estimates and Forecasts, by Service, 2018-2030 (USD Million)
Table 47 Spain Formulation Development Outsourcing Market Estimates and Forecasts, by Formulation, 2018-2030 (USD Million)
Table 48 Spain Formulation Development Outsourcing Market Estimates and Forecasts, by Therapeutic Area, 2018-2030 (USD Million)
Table 49 Spain Formulation Development Outsourcing Market Estimates and Forecasts, by End Use, 2018-2030 (USD Million)
Table 50 Netherlands Formulation Development Outsourcing Market Estimates and Forecasts, by Service, 2018-2030 (USD Million)
Table 51 Netherlands Formulation Development Outsourcing Market Estimates and Forecasts, by Formulation, 2018-2030 (USD Million)
Table 52 Netherlands Formulation Development Outsourcing Market Estimates and Forecasts, by Therapeutic Area, 2018-2030 (USD Million)
Table 53 Netherlands Formulation Development Outsourcing Market Estimates and Forecasts, by End Use, 2018-2030 (USD Million)
Table 54 Switzerland Formulation Development Outsourcing Market Estimates and Forecasts, by Service, 2018-2030 (USD Million)
Table 55 Switzerland Formulation Development Outsourcing Market Estimates and Forecasts, by Formulation, 2018-2030 (USD Million)
Table 56 Switzerland Formulation Development Outsourcing Market Estimates and Forecasts, by Therapeutic Area, 2018-2030 (USD Million)
Table 57 Switzerland Formulation Development Outsourcing Market Estimates and Forecasts, by End Use, 2018-2030 (USD Million)
Table 58 Sweden Formulation Development Outsourcing Market Estimates and Forecasts, by Service, 2018-2030 (USD Million)
Table 59 Sweden Formulation Development Outsourcing Market Estimates and Forecasts, by Formulation, 2018-2030 (USD Million)
Table 60 Sweden Formulation Development Outsourcing Market Estimates and Forecasts, by Therapeutic Area, 2018-2030 (USD Million)
Table 61 Sweden Formulation Development Outsourcing Market Estimates and Forecasts, by End Use, 2018-2030 (USD Million)
Table 62 Denmark Formulation Development Outsourcing Market Estimates and Forecasts, by Service, 2018-2030 (USD Million)
Table 63 Denmark Formulation Development Outsourcing Market Estimates and Forecasts, by Formulation, 2018-2030 (USD Million)
Table 64 Denmark Formulation Development Outsourcing Market Estimates and Forecasts, by Therapeutic Area, 2018-2030 (USD Million)
Table 65 Denmark Formulation Development Outsourcing Market Estimates and Forecasts, by End Use, 2018-2030 (USD Million)
Table 66 Norway Formulation Development Outsourcing Market Estimates and Forecasts, by Service, 2018-2030 (USD Million)
Table 67 Norway Formulation Development Outsourcing Market Estimates and Forecasts, by Formulation, 2018-2030 (USD Million)
Table 68 Norway Formulation Development Outsourcing Market Estimates and Forecasts, by Therapeutic Area, 2018-2030 (USD Million)
Table 69 Norway Formulation Development Outsourcing Market Estimates and Forecasts, by End Use, 2018-2030 (USD Million)
Table 70 Asia Pacific Formulation Development Outsourcing Market Estimates and Forecasts, by Country, 2018-2030 (USD Million)
Table 71 Asia Pacific Formulation Development Outsourcing Market Estimates and Forecasts, by Service, 2018-2030 (USD Million)
Table 72 Asia Pacific Formulation Development Outsourcing Market Estimates and Forecasts, by Formulation, 2018-2030 (USD Million)
Table 73 Asia Pacific Formulation Development Outsourcing Market Estimates and Forecasts, by Therapeutic Area, 2018-2030 (USD Million)
Table 74 Asia Pacific Formulation Development Outsourcing Market Estimates and Forecasts, by End Use, 2018-2030 (USD Million)
Table 75 China Formulation Development Outsourcing Market Estimates and Forecasts, by Service, 2018-2030 (USD Million)
Table 76 China Formulation Development Outsourcing Market Estimates and Forecasts, by Formulation, 2018-2030 (USD Million)
Table 77 China Formulation Development Outsourcing Market Estimates and Forecasts, by Therapeutic Area, 2018-2030 (USD Million)
Table 78 China Formulation Development Outsourcing Market Estimates and Forecasts, by End Use, 2018-2030 (USD Million)
Table 79 India Formulation Development Outsourcing Market Estimates and Forecasts, by Service, 2018-2030 (USD Million)
Table 80 India Formulation Development Outsourcing Market Estimates and Forecasts, by Formulation, 2018-2030 (USD Million)
Table 81 India Formulation Development Outsourcing Market Estimates and Forecasts, by Therapeutic Area, 2018-2030 (USD Million)
Table 82 India Formulation Development Outsourcing Market Estimates and Forecasts, by End Use, 2018-2030 (USD Million)
Table 83 Japan Formulation Development Outsourcing Market Estimates and Forecasts, by Service, 2018-2030 (USD Million)
Table 84 Japan Formulation Development Outsourcing Market Estimates and Forecasts, by Formulation, 2018-2030 (USD Million)
Table 85 Japan Formulation Development Outsourcing Market Estimates and Forecasts, by Therapeutic Area, 2018-2030 (USD Million)
Table 86 Japan Formulation Development Outsourcing Market Estimates and Forecasts, by End Use, 2018-2030 (USD Million)
Table 87 Australia Formulation Development Outsourcing Market Estimates and Forecasts, by Service, 2018-2030 (USD Million)
Table 88 Australia Formulation Development Outsourcing Market Estimates and Forecasts, by Formulation, 2018-2030 (USD Million)
Table 89 Australia Formulation Development Outsourcing Market Estimates and Forecasts, by Therapeutic Area, 2018-2030 (USD Million)
Table 90 Australia Formulation Development Outsourcing Market Estimates and Forecasts, by End Use, 2018-2030 (USD Million)
Table 91 South Korea Formulation Development Outsourcing Market Estimates and Forecasts, by Service, 2018-2030 (USD Million)
Table 92 South Korea Formulation Development Outsourcing Market Estimates and Forecasts, by Formulation, 2018-2030 (USD Million)
Table 93 South Korea Formulation Development Outsourcing Market Estimates and Forecasts, by Therapeutic Area, 2018-2030 (USD Million)
Table 94 South Korea Formulation Development Outsourcing Market Estimates and Forecasts, by End Use, 2018-2030 (USD Million)
Table 95 Indonesia Formulation Development Outsourcing Market Estimates and Forecasts, by Service, 2018-2030 (USD Million)
Table 96 Indonesia Formulation Development Outsourcing Market Estimates and Forecasts, by Formulation, 2018-2030 (USD Million)
Table 97 Indonesia Formulation Development Outsourcing Market Estimates and Forecasts, by Therapeutic Area, 2018-2030 (USD Million)
Table 98 Indonesia Formulation Development Outsourcing Market Estimates and Forecasts, by End Use, 2018-2030 (USD Million)
Table 99 Malaysia Formulation Development Outsourcing Market Estimates and Forecasts, by Service, 2018-2030 (USD Million)
Table 100 Malaysia Formulation Development Outsourcing Market Estimates and Forecasts, by Formulation, 2018-2030 (USD Million)
Table 101 Malaysia Formulation Development Outsourcing Market Estimates and Forecasts, by Therapeutic Area, 2018-2030 (USD Million)
Table 102 Malaysia Formulation Development Outsourcing Market Estimates and Forecasts, by End Use, 2018-2030 (USD Million)
Table 103 Singapore Formulation Development Outsourcing Market Estimates and Forecasts, by Service, 2018-2030 (USD Million)
Table 104 Singapore Formulation Development Outsourcing Market Estimates and Forecasts, by Formulation, 2018-2030 (USD Million)
Table 105 Singapore Formulation Development Outsourcing Market Estimates and Forecasts, by Therapeutic Area, 2018-2030 (USD Million)
Table 106 Singapore Formulation Development Outsourcing Market Estimates and Forecasts, by End Use, 2018-2030 (USD Million)
Table 107 Thailand Formulation Development Outsourcing Market Estimates and Forecasts, by Service, 2018-2030 (USD Million)
Table 108 Thailand Formulation Development Outsourcing Market Estimates and Forecasts, by Formulation, 2018-2030 (USD Million)
Table 109 Thailand Formulation Development Outsourcing Market Estimates and Forecasts, by Therapeutic Area, 2018-2030 (USD Million)
Table 110 Thailand Formulation Development Outsourcing Market Estimates and Forecasts, by End Use, 2018-2030 (USD Million)
Table 111 Taiwan Formulation Development Outsourcing Market Estimates and Forecasts, by Service, 2018-2030 (USD Million)
Table 112 Taiwan Formulation Development Outsourcing Market Estimates and Forecasts, by Formulation, 2018-2030 (USD Million)
Table 113 Taiwan Formulation Development Outsourcing Market Estimates and Forecasts, by Therapeutic Area, 2018-2030 (USD Million)
Table 114 Taiwan Formulation Development Outsourcing Market Estimates and Forecasts, by End Use, 2018-2030 (USD Million)
Table 115 Latin America Formulation Development Outsourcing Market Estimates and Forecasts, by Country, 2018-2030 (USD Million)
Table 116 Latin America Formulation Development Outsourcing Market Estimates and Forecasts, by Service, 2018-2030 (USD Million)
Table 117 Latin America Formulation Development Outsourcing Market Estimates and Forecasts, by Formulation, 2018-2030 (USD Million)
Table 118 Latin America Formulation Development Outsourcing Market Estimates and Forecasts, by Therapeutic Area, 2018-2030 (USD Million)
Table 119 Latin America Formulation Development Outsourcing Market Estimates and Forecasts, by End Use, 2018-2030 (USD Million)
Table 120 Brazil Formulation Development Outsourcing Market Estimates and Forecasts, by Service, 2018-2030 (USD Million)
Table 121 Brazil Formulation Development Outsourcing Market Estimates and Forecasts, by Formulation, 2018-2030 (USD Million)
Table 122 Brazil Formulation Development Outsourcing Market Estimates and Forecasts, by Therapeutic Area, 2018-2030 (USD Million)
Table 123 Brazil Formulation Development Outsourcing Market Estimates and Forecasts, by End Use, 2018-2030 (USD Million)
Table 124 Argentina Formulation Development Outsourcing Market Estimates and Forecasts, by Service, 2018-2030 (USD Million)
Table 125 Argentina Formulation Development Outsourcing Market Estimates and Forecasts, by Formulation, 2018-2030 (USD Million)
Table 126 Argentina Formulation Development Outsourcing Market Estimates and Forecasts, by Therapeutic Area, 2018-2030 (USD Million)
Table 127 Argentina Formulation Development Outsourcing Market Estimates and Forecasts, by End Use, 2018-2030 (USD Million)
Table 128 Colombia Formulation Development Outsourcing Market Estimates and Forecasts, by Service, 2018-2030 (USD Million)
Table 129 Colombia Formulation Development Outsourcing Market Estimates and Forecasts, by Formulation, 2018-2030 (USD Million)
Table 130 Colombia Formulation Development Outsourcing Market Estimates and Forecasts, by Therapeutic Area, 2018-2030 (USD Million)
Table 131 Colombia Formulation Development Outsourcing Market Estimates and Forecasts, by End Use, 2018-2030 (USD Million)
Table 132 Chile Formulation Development Outsourcing Market Estimates and Forecasts, by Service, 2018-2030 (USD Million)
Table 133 Chile Formulation Development Outsourcing Market Estimates and Forecasts, by Formulation, 2018-2030 (USD Million)
Table 134 Chile Formulation Development Outsourcing Market Estimates and Forecasts, by Therapeutic Area, 2018-2030 (USD Million)
Table 135 Chile Formulation Development Outsourcing Market Estimates and Forecasts, by End Use, 2018-2030 (USD Million)
Table 136 Middle East & Africa Formulation Development Outsourcing Market Estimates and Forecasts, by Country, 2018-2030 (USD Million)
Table 137 Middle East & Africa Formulation Development Outsourcing Market Estimates and Forecasts, by Service, 2018-2030 (USD Million)
Table 138 Middle East & Africa Formulation Development Outsourcing Market Estimates and Forecasts, by Formulation, 2018-2030 (USD Million)
Table 139 Middle East & Africa Formulation Development Outsourcing Market Estimates and Forecasts, by Therapeutic Area, 2018-2030 (USD Million)
Table 140 Middle East & Africa Formulation Development Outsourcing Market Estimates and Forecasts, by End Use, 2018-2030 (USD Million)
Table 141 South Africa Formulation Development Outsourcing Market Estimates and Forecasts, by Service, 2018-2030 (USD Million)
Table 142 South Africa Formulation Development Outsourcing Market Estimates and Forecasts, by Formulation, 2018-2030 (USD Million)
Table 143 South Africa Formulation Development Outsourcing Market Estimates and Forecasts, by Therapeutic Area, 2018-2030 (USD Million)
Table 144 South Africa Formulation Development Outsourcing Market Estimates and Forecasts, by End Use, 2018-2030 (USD Million)
Table 145 Saudi Arabia Formulation Development Outsourcing Market Estimates and Forecasts, by Service, 2018-2030 (USD Million)
Table 146 Saudi Arabia Formulation Development Outsourcing Market Estimates and Forecasts, by Formulation, 2018-2030 (USD Million)
Table 147 Saudi Arabia Formulation Development Outsourcing Market Estimates and Forecasts, by Therapeutic Area, 2018-2030 (USD Million)
Table 148 Saudi Arabia Formulation Development Outsourcing Market Estimates and Forecasts, by End Use, 2018-2030 (USD Million)
Table 149 UAE Formulation Development Outsourcing Market Estimates and Forecasts, by Service, 2018-2030 (USD Million)
Table 150 UAE Formulation Development Outsourcing Market Estimates and Forecasts, by Formulation, 2018-2030 (USD Million)
Table 151 UAE Formulation Development Outsourcing Market Estimates and Forecasts, by Therapeutic Area, 2018-2030 (USD Million)
Table 152 UAE Formulation Development Outsourcing Market Estimates and Forecasts, by End Use, 2018-2030 (USD Million)
Table 153 Egypt Formulation Development Outsourcing Market Estimates and Forecasts, by Service, 2018-2030 (USD Million)
Table 154 Egypt Formulation Development Outsourcing Market Estimates and Forecasts, by Formulation, 2018-2030 (USD Million)
Table 155 Egypt Formulation Development Outsourcing Market Estimates and Forecasts, by Therapeutic Area, 2018-2030 (USD Million)
Table 156 Egypt Formulation Development Outsourcing Market Estimates and Forecasts, by End Use, 2018-2030 (USD Million)
Table 157 Israel Formulation Development Outsourcing Market Estimates and Forecasts, by Service, 2018-2030 (USD Million)
Table 158 Israel Formulation Development Outsourcing Market Estimates and Forecasts, by Formulation, 2018-2030 (USD Million)
Table 159 Israel Formulation Development Outsourcing Market Estimates and Forecasts, by Therapeutic Area, 2018-2030 (USD Million)
Table 160 Israel Formulation Development Outsourcing Market Estimates and Forecasts, by End Use, 2018-2030 (USD Million)
Table 161 Kuwait Formulation Development Outsourcing Market Estimates and Forecasts, by Service, 2018-2030 (USD Million)
Table 162 Kuwait Formulation Development Outsourcing Market Estimates and Forecasts, by Formulation, 2018-2030 (USD Million)
Table 163 Kuwait Formulation Development Outsourcing Market Estimates and Forecasts, by Therapeutic Area, 2018-2030 (USD Million)
Table 164 Kuwait Formulation Development Outsourcing Market Estimates and Forecasts, by End Use, 2018-2030 (USD Million)
Table 2 List of Abbreviations
Table 3 Global Formulation Development Outsourcing Market Estimates and Forecasts, by Service, 2018-2030 (USD Million)
Table 4 Global Formulation Development Outsourcing Market Estimates and Forecasts, by Formulation, 2018-2030 (USD Million)
Table 5 Global Formulation Development Outsourcing Market Estimates and Forecasts, by Therapeutic Area, 2018-2030 (USD Million)
Table 6 Global Formulation Development Outsourcing Market Estimates and Forecasts, by End Use, 2018-2030 (USD Million)
Table 7 Global Formulation Development Outsourcing Market Estimates and Forecasts, by Region, 2018-2030 (USD Million)
Table 8 North America Formulation Development Outsourcing Market Estimates and Forecasts, by Country, 2018-2030 (USD Million)
Table 9 North America Formulation Development Outsourcing Market Estimates and Forecasts, by Service, 2018-2030 (USD Million)
Table 10 North America Formulation Development Outsourcing Market Estimates and Forecasts, by Formulation, 2018-2030 (USD Million)
Table 11 North America Formulation Development Outsourcing Market Estimates and Forecasts, by Therapeutic Area, 2018-2030 (USD Million)
Table 12 North America Formulation Development Outsourcing Market Estimates and Forecasts, by End Use, 2018-2030 (USD Million)
Table 13 U.S. Formulation Development Outsourcing Market Estimates and Forecasts, by Service, 2018-2030 (USD Million)
Table 14 U.S. Formulation Development Outsourcing Market Estimates and Forecasts, by Formulation, 2018-2030 (USD Million)
Table 15 U.S. Formulation Development Outsourcing Market Estimates and Forecasts, by Therapeutic Area, 2018-2030 (USD Million)
Table 16 U.S. Formulation Development Outsourcing Market Estimates and Forecasts, by End Use, 2018-2030 (USD Million)
Table 17 Canada Formulation Development Outsourcing Market Estimates and Forecasts, by Service, 2018-2030 (USD Million)
Table 18 Canada Formulation Development Outsourcing Market Estimates and Forecasts, by Formulation, 2018-2030 (USD Million)
Table 19 Canada Formulation Development Outsourcing Market Estimates and Forecasts, by Therapeutic Area, 2018-2030 (USD Million)
Table 20 Canada Formulation Development Outsourcing Market Estimates and Forecasts, by End Use, 2018-2030 (USD Million)
Table 21 Mexico Formulation Development Outsourcing Market Estimates and Forecasts, by Service, 2018-2030 (USD Million)
Table 22 Mexico Formulation Development Outsourcing Market Estimates and Forecasts, by Formulation, 2018-2030 (USD Million)
Table 23 Mexico Formulation Development Outsourcing Market Estimates and Forecasts, by Therapeutic Area, 2018-2030 (USD Million)
Table 24 Mexico Formulation Development Outsourcing Market Estimates and Forecasts, by End Use, 2018-2030 (USD Million)
Table 25 Europe Formulation Development Outsourcing Market Estimates and Forecasts, by Country, 2018-2030 (USD Million)
Table 26 Europe Formulation Development Outsourcing Market Estimates and Forecasts, by Service, 2018-2030 (USD Million)
Table 27 Europe Formulation Development Outsourcing Market Estimates and Forecasts, by Formulation, 2018-2030 (USD Million)
Table 28 Europe Formulation Development Outsourcing Market Estimates and Forecasts, by Therapeutic Area, 2018-2030 (USD Million)
Table 29 Europe Formulation Development Outsourcing Market Estimates and Forecasts, by End Use, 2018-2030 (USD Million)
Table 30 UK Formulation Development Outsourcing Market Estimates and Forecasts, by Service, 2018-2030 (USD Million)
Table 31 UK Formulation Development Outsourcing Market Estimates and Forecasts, by Formulation, 2018-2030 (USD Million)
Table 32 UK Formulation Development Outsourcing Market Estimates and Forecasts, by Therapeutic Area, 2018-2030 (USD Million)
Table 33 UK Formulation Development Outsourcing Market Estimates and Forecasts, by End Use, 2018-2030 (USD Million)
Table 34 Germany Formulation Development Outsourcing Market Estimates and Forecasts, by Service, 2018-2030 (USD Million)
Table 35 Germany Formulation Development Outsourcing Market Estimates and Forecasts, by Formulation, 2018-2030 (USD Million)
Table 36 Germany Formulation Development Outsourcing Market Estimates and Forecasts, by Therapeutic Area, 2018-2030 (USD Million)
Table 37 Germany Formulation Development Outsourcing Market Estimates and Forecasts, by End Use, 2018-2030 (USD Million)
Table 38 France Formulation Development Outsourcing Market Estimates and Forecasts, by Service, 2018-2030 (USD Million)
Table 39 France Formulation Development Outsourcing Market Estimates and Forecasts, by Formulation, 2018-2030 (USD Million)
Table 40 France Formulation Development Outsourcing Market Estimates and Forecasts, by Therapeutic Area, 2018-2030 (USD Million)
Table 41 France Formulation Development Outsourcing Market Estimates and Forecasts, by End Use, 2018-2030 (USD Million)
Table 42 Italy Formulation Development Outsourcing Market Estimates and Forecasts, by Service, 2018-2030 (USD Million)
Table 43 Italy Formulation Development Outsourcing Market Estimates and Forecasts, by Formulation, 2018-2030 (USD Million)
Table 44 Italy Formulation Development Outsourcing Market Estimates and Forecasts, by Therapeutic Area, 2018-2030 (USD Million)
Table 45 Italy Formulation Development Outsourcing Market Estimates and Forecasts, by End Use, 2018-2030 (USD Million)
Table 46 Spain Formulation Development Outsourcing Market Estimates and Forecasts, by Service, 2018-2030 (USD Million)
Table 47 Spain Formulation Development Outsourcing Market Estimates and Forecasts, by Formulation, 2018-2030 (USD Million)
Table 48 Spain Formulation Development Outsourcing Market Estimates and Forecasts, by Therapeutic Area, 2018-2030 (USD Million)
Table 49 Spain Formulation Development Outsourcing Market Estimates and Forecasts, by End Use, 2018-2030 (USD Million)
Table 50 Netherlands Formulation Development Outsourcing Market Estimates and Forecasts, by Service, 2018-2030 (USD Million)
Table 51 Netherlands Formulation Development Outsourcing Market Estimates and Forecasts, by Formulation, 2018-2030 (USD Million)
Table 52 Netherlands Formulation Development Outsourcing Market Estimates and Forecasts, by Therapeutic Area, 2018-2030 (USD Million)
Table 53 Netherlands Formulation Development Outsourcing Market Estimates and Forecasts, by End Use, 2018-2030 (USD Million)
Table 54 Switzerland Formulation Development Outsourcing Market Estimates and Forecasts, by Service, 2018-2030 (USD Million)
Table 55 Switzerland Formulation Development Outsourcing Market Estimates and Forecasts, by Formulation, 2018-2030 (USD Million)
Table 56 Switzerland Formulation Development Outsourcing Market Estimates and Forecasts, by Therapeutic Area, 2018-2030 (USD Million)
Table 57 Switzerland Formulation Development Outsourcing Market Estimates and Forecasts, by End Use, 2018-2030 (USD Million)
Table 58 Sweden Formulation Development Outsourcing Market Estimates and Forecasts, by Service, 2018-2030 (USD Million)
Table 59 Sweden Formulation Development Outsourcing Market Estimates and Forecasts, by Formulation, 2018-2030 (USD Million)
Table 60 Sweden Formulation Development Outsourcing Market Estimates and Forecasts, by Therapeutic Area, 2018-2030 (USD Million)
Table 61 Sweden Formulation Development Outsourcing Market Estimates and Forecasts, by End Use, 2018-2030 (USD Million)
Table 62 Denmark Formulation Development Outsourcing Market Estimates and Forecasts, by Service, 2018-2030 (USD Million)
Table 63 Denmark Formulation Development Outsourcing Market Estimates and Forecasts, by Formulation, 2018-2030 (USD Million)
Table 64 Denmark Formulation Development Outsourcing Market Estimates and Forecasts, by Therapeutic Area, 2018-2030 (USD Million)
Table 65 Denmark Formulation Development Outsourcing Market Estimates and Forecasts, by End Use, 2018-2030 (USD Million)
Table 66 Norway Formulation Development Outsourcing Market Estimates and Forecasts, by Service, 2018-2030 (USD Million)
Table 67 Norway Formulation Development Outsourcing Market Estimates and Forecasts, by Formulation, 2018-2030 (USD Million)
Table 68 Norway Formulation Development Outsourcing Market Estimates and Forecasts, by Therapeutic Area, 2018-2030 (USD Million)
Table 69 Norway Formulation Development Outsourcing Market Estimates and Forecasts, by End Use, 2018-2030 (USD Million)
Table 70 Asia Pacific Formulation Development Outsourcing Market Estimates and Forecasts, by Country, 2018-2030 (USD Million)
Table 71 Asia Pacific Formulation Development Outsourcing Market Estimates and Forecasts, by Service, 2018-2030 (USD Million)
Table 72 Asia Pacific Formulation Development Outsourcing Market Estimates and Forecasts, by Formulation, 2018-2030 (USD Million)
Table 73 Asia Pacific Formulation Development Outsourcing Market Estimates and Forecasts, by Therapeutic Area, 2018-2030 (USD Million)
Table 74 Asia Pacific Formulation Development Outsourcing Market Estimates and Forecasts, by End Use, 2018-2030 (USD Million)
Table 75 China Formulation Development Outsourcing Market Estimates and Forecasts, by Service, 2018-2030 (USD Million)
Table 76 China Formulation Development Outsourcing Market Estimates and Forecasts, by Formulation, 2018-2030 (USD Million)
Table 77 China Formulation Development Outsourcing Market Estimates and Forecasts, by Therapeutic Area, 2018-2030 (USD Million)
Table 78 China Formulation Development Outsourcing Market Estimates and Forecasts, by End Use, 2018-2030 (USD Million)
Table 79 India Formulation Development Outsourcing Market Estimates and Forecasts, by Service, 2018-2030 (USD Million)
Table 80 India Formulation Development Outsourcing Market Estimates and Forecasts, by Formulation, 2018-2030 (USD Million)
Table 81 India Formulation Development Outsourcing Market Estimates and Forecasts, by Therapeutic Area, 2018-2030 (USD Million)
Table 82 India Formulation Development Outsourcing Market Estimates and Forecasts, by End Use, 2018-2030 (USD Million)
Table 83 Japan Formulation Development Outsourcing Market Estimates and Forecasts, by Service, 2018-2030 (USD Million)
Table 84 Japan Formulation Development Outsourcing Market Estimates and Forecasts, by Formulation, 2018-2030 (USD Million)
Table 85 Japan Formulation Development Outsourcing Market Estimates and Forecasts, by Therapeutic Area, 2018-2030 (USD Million)
Table 86 Japan Formulation Development Outsourcing Market Estimates and Forecasts, by End Use, 2018-2030 (USD Million)
Table 87 Australia Formulation Development Outsourcing Market Estimates and Forecasts, by Service, 2018-2030 (USD Million)
Table 88 Australia Formulation Development Outsourcing Market Estimates and Forecasts, by Formulation, 2018-2030 (USD Million)
Table 89 Australia Formulation Development Outsourcing Market Estimates and Forecasts, by Therapeutic Area, 2018-2030 (USD Million)
Table 90 Australia Formulation Development Outsourcing Market Estimates and Forecasts, by End Use, 2018-2030 (USD Million)
Table 91 South Korea Formulation Development Outsourcing Market Estimates and Forecasts, by Service, 2018-2030 (USD Million)
Table 92 South Korea Formulation Development Outsourcing Market Estimates and Forecasts, by Formulation, 2018-2030 (USD Million)
Table 93 South Korea Formulation Development Outsourcing Market Estimates and Forecasts, by Therapeutic Area, 2018-2030 (USD Million)
Table 94 South Korea Formulation Development Outsourcing Market Estimates and Forecasts, by End Use, 2018-2030 (USD Million)
Table 95 Indonesia Formulation Development Outsourcing Market Estimates and Forecasts, by Service, 2018-2030 (USD Million)
Table 96 Indonesia Formulation Development Outsourcing Market Estimates and Forecasts, by Formulation, 2018-2030 (USD Million)
Table 97 Indonesia Formulation Development Outsourcing Market Estimates and Forecasts, by Therapeutic Area, 2018-2030 (USD Million)
Table 98 Indonesia Formulation Development Outsourcing Market Estimates and Forecasts, by End Use, 2018-2030 (USD Million)
Table 99 Malaysia Formulation Development Outsourcing Market Estimates and Forecasts, by Service, 2018-2030 (USD Million)
Table 100 Malaysia Formulation Development Outsourcing Market Estimates and Forecasts, by Formulation, 2018-2030 (USD Million)
Table 101 Malaysia Formulation Development Outsourcing Market Estimates and Forecasts, by Therapeutic Area, 2018-2030 (USD Million)
Table 102 Malaysia Formulation Development Outsourcing Market Estimates and Forecasts, by End Use, 2018-2030 (USD Million)
Table 103 Singapore Formulation Development Outsourcing Market Estimates and Forecasts, by Service, 2018-2030 (USD Million)
Table 104 Singapore Formulation Development Outsourcing Market Estimates and Forecasts, by Formulation, 2018-2030 (USD Million)
Table 105 Singapore Formulation Development Outsourcing Market Estimates and Forecasts, by Therapeutic Area, 2018-2030 (USD Million)
Table 106 Singapore Formulation Development Outsourcing Market Estimates and Forecasts, by End Use, 2018-2030 (USD Million)
Table 107 Thailand Formulation Development Outsourcing Market Estimates and Forecasts, by Service, 2018-2030 (USD Million)
Table 108 Thailand Formulation Development Outsourcing Market Estimates and Forecasts, by Formulation, 2018-2030 (USD Million)
Table 109 Thailand Formulation Development Outsourcing Market Estimates and Forecasts, by Therapeutic Area, 2018-2030 (USD Million)
Table 110 Thailand Formulation Development Outsourcing Market Estimates and Forecasts, by End Use, 2018-2030 (USD Million)
Table 111 Taiwan Formulation Development Outsourcing Market Estimates and Forecasts, by Service, 2018-2030 (USD Million)
Table 112 Taiwan Formulation Development Outsourcing Market Estimates and Forecasts, by Formulation, 2018-2030 (USD Million)
Table 113 Taiwan Formulation Development Outsourcing Market Estimates and Forecasts, by Therapeutic Area, 2018-2030 (USD Million)
Table 114 Taiwan Formulation Development Outsourcing Market Estimates and Forecasts, by End Use, 2018-2030 (USD Million)
Table 115 Latin America Formulation Development Outsourcing Market Estimates and Forecasts, by Country, 2018-2030 (USD Million)
Table 116 Latin America Formulation Development Outsourcing Market Estimates and Forecasts, by Service, 2018-2030 (USD Million)
Table 117 Latin America Formulation Development Outsourcing Market Estimates and Forecasts, by Formulation, 2018-2030 (USD Million)
Table 118 Latin America Formulation Development Outsourcing Market Estimates and Forecasts, by Therapeutic Area, 2018-2030 (USD Million)
Table 119 Latin America Formulation Development Outsourcing Market Estimates and Forecasts, by End Use, 2018-2030 (USD Million)
Table 120 Brazil Formulation Development Outsourcing Market Estimates and Forecasts, by Service, 2018-2030 (USD Million)
Table 121 Brazil Formulation Development Outsourcing Market Estimates and Forecasts, by Formulation, 2018-2030 (USD Million)
Table 122 Brazil Formulation Development Outsourcing Market Estimates and Forecasts, by Therapeutic Area, 2018-2030 (USD Million)
Table 123 Brazil Formulation Development Outsourcing Market Estimates and Forecasts, by End Use, 2018-2030 (USD Million)
Table 124 Argentina Formulation Development Outsourcing Market Estimates and Forecasts, by Service, 2018-2030 (USD Million)
Table 125 Argentina Formulation Development Outsourcing Market Estimates and Forecasts, by Formulation, 2018-2030 (USD Million)
Table 126 Argentina Formulation Development Outsourcing Market Estimates and Forecasts, by Therapeutic Area, 2018-2030 (USD Million)
Table 127 Argentina Formulation Development Outsourcing Market Estimates and Forecasts, by End Use, 2018-2030 (USD Million)
Table 128 Colombia Formulation Development Outsourcing Market Estimates and Forecasts, by Service, 2018-2030 (USD Million)
Table 129 Colombia Formulation Development Outsourcing Market Estimates and Forecasts, by Formulation, 2018-2030 (USD Million)
Table 130 Colombia Formulation Development Outsourcing Market Estimates and Forecasts, by Therapeutic Area, 2018-2030 (USD Million)
Table 131 Colombia Formulation Development Outsourcing Market Estimates and Forecasts, by End Use, 2018-2030 (USD Million)
Table 132 Chile Formulation Development Outsourcing Market Estimates and Forecasts, by Service, 2018-2030 (USD Million)
Table 133 Chile Formulation Development Outsourcing Market Estimates and Forecasts, by Formulation, 2018-2030 (USD Million)
Table 134 Chile Formulation Development Outsourcing Market Estimates and Forecasts, by Therapeutic Area, 2018-2030 (USD Million)
Table 135 Chile Formulation Development Outsourcing Market Estimates and Forecasts, by End Use, 2018-2030 (USD Million)
Table 136 Middle East & Africa Formulation Development Outsourcing Market Estimates and Forecasts, by Country, 2018-2030 (USD Million)
Table 137 Middle East & Africa Formulation Development Outsourcing Market Estimates and Forecasts, by Service, 2018-2030 (USD Million)
Table 138 Middle East & Africa Formulation Development Outsourcing Market Estimates and Forecasts, by Formulation, 2018-2030 (USD Million)
Table 139 Middle East & Africa Formulation Development Outsourcing Market Estimates and Forecasts, by Therapeutic Area, 2018-2030 (USD Million)
Table 140 Middle East & Africa Formulation Development Outsourcing Market Estimates and Forecasts, by End Use, 2018-2030 (USD Million)
Table 141 South Africa Formulation Development Outsourcing Market Estimates and Forecasts, by Service, 2018-2030 (USD Million)
Table 142 South Africa Formulation Development Outsourcing Market Estimates and Forecasts, by Formulation, 2018-2030 (USD Million)
Table 143 South Africa Formulation Development Outsourcing Market Estimates and Forecasts, by Therapeutic Area, 2018-2030 (USD Million)
Table 144 South Africa Formulation Development Outsourcing Market Estimates and Forecasts, by End Use, 2018-2030 (USD Million)
Table 145 Saudi Arabia Formulation Development Outsourcing Market Estimates and Forecasts, by Service, 2018-2030 (USD Million)
Table 146 Saudi Arabia Formulation Development Outsourcing Market Estimates and Forecasts, by Formulation, 2018-2030 (USD Million)
Table 147 Saudi Arabia Formulation Development Outsourcing Market Estimates and Forecasts, by Therapeutic Area, 2018-2030 (USD Million)
Table 148 Saudi Arabia Formulation Development Outsourcing Market Estimates and Forecasts, by End Use, 2018-2030 (USD Million)
Table 149 UAE Formulation Development Outsourcing Market Estimates and Forecasts, by Service, 2018-2030 (USD Million)
Table 150 UAE Formulation Development Outsourcing Market Estimates and Forecasts, by Formulation, 2018-2030 (USD Million)
Table 151 UAE Formulation Development Outsourcing Market Estimates and Forecasts, by Therapeutic Area, 2018-2030 (USD Million)
Table 152 UAE Formulation Development Outsourcing Market Estimates and Forecasts, by End Use, 2018-2030 (USD Million)
Table 153 Egypt Formulation Development Outsourcing Market Estimates and Forecasts, by Service, 2018-2030 (USD Million)
Table 154 Egypt Formulation Development Outsourcing Market Estimates and Forecasts, by Formulation, 2018-2030 (USD Million)
Table 155 Egypt Formulation Development Outsourcing Market Estimates and Forecasts, by Therapeutic Area, 2018-2030 (USD Million)
Table 156 Egypt Formulation Development Outsourcing Market Estimates and Forecasts, by End Use, 2018-2030 (USD Million)
Table 157 Israel Formulation Development Outsourcing Market Estimates and Forecasts, by Service, 2018-2030 (USD Million)
Table 158 Israel Formulation Development Outsourcing Market Estimates and Forecasts, by Formulation, 2018-2030 (USD Million)
Table 159 Israel Formulation Development Outsourcing Market Estimates and Forecasts, by Therapeutic Area, 2018-2030 (USD Million)
Table 160 Israel Formulation Development Outsourcing Market Estimates and Forecasts, by End Use, 2018-2030 (USD Million)
Table 161 Kuwait Formulation Development Outsourcing Market Estimates and Forecasts, by Service, 2018-2030 (USD Million)
Table 162 Kuwait Formulation Development Outsourcing Market Estimates and Forecasts, by Formulation, 2018-2030 (USD Million)
Table 163 Kuwait Formulation Development Outsourcing Market Estimates and Forecasts, by Therapeutic Area, 2018-2030 (USD Million)
Table 164 Kuwait Formulation Development Outsourcing Market Estimates and Forecasts, by End Use, 2018-2030 (USD Million)
List of Figures
Figure 1 Market research process
Figure 2 Information procurement
Figure 3 Primary research pattern
Figure 4 Market research approaches
Figure 5 Market formulation & validation
Figure 6 Commodity flow analysis
Figure 7 Value-chain-based sizing & forecasting
Figure 8 QFD model sizing & forecasting
Figure 9 Bottom-up approach
Figure 10 Market snapshot
Figure 11 Segment snapshot 1
Figure 12 Segment snapshot 2
Figure 13 Competitive landscape snapshot
Figure 14 Parent market outlook, 2024 (USD Billion)
Figure 15 Ancillary market outlook, 2024 (USD Billion)
Figure 16 Formulation Development Outsourcing Market dynamics
Figure 17 Porter’s five forces analysis
Figure 18 PESTEL analysis
Figure 19 Formulation Development Outsourcing Market: Service outlook and key takeaways
Figure 20 Formulation Development Outsourcing Market: Service movement analysis
Figure 21 Preformulation Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 22 Formulation Development Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 23 Formulation Development Outsourcing Market: Formulation outlook and key takeaways
Figure 24 Formulation Development Outsourcing Market: Formulation movement analysis
Figure 25 Oral Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 26 Injectable Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 27 Topical Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 28 Others Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 29 Formulation Development Outsourcing Market: Therapeutic Area outlook and key takeaways
Figure 30 Formulation Development Outsourcing Market: Therapeutic Area Movement Analysis
Figure 31 Oncology Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 32 Infectious Disease Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 33 Neurology Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 34 Hematology Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 35 Respiratory Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 36 Cardiovascular Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 37 Dermatology Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 38 Others Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 39 Formulation Development Outsourcing Market: End Use outlook and key takeaways
Figure 40 Formulation Development Outsourcing Market: End Use movement analysis
Figure 41 Pharmaceutical and Biopharmaceutical Companies Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 42 Government and Academic Institutes Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 43 Others Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 44 Regional Marketplace: Key Takeaways
Figure 45 North America Formulation Development Outsourcing Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 46 Key country dynamics
Figure 47 U.S. Formulation Development Outsourcing Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 48 Key country dynamics
Figure 49 Canada Formulation Development Outsourcing Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 50 Key country dynamics
Figure 51 Mexico Formulation Development Outsourcing Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 52 Europe Formulation Development Outsourcing Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 53 Key country dynamics
Figure 54 UK Formulation Development Outsourcing Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 55 Key country dynamics
Figure 56 Germany Formulation Development Outsourcing Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 57 Key country dynamics
Figure 58 France Formulation Development Outsourcing Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 59 Key country dynamics
Figure 60 Italy Formulation Development Outsourcing Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 61 Key country dynamics
Figure 62 Spain Formulation Development Outsourcing Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 63 Key country dynamics
Figure 64 Netherlands Formulation Development Outsourcing Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 65 Key country dynamics
Figure 66 Switzerland Formulation Development Outsourcing Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 67 Key country dynamics
Figure 68 Sweden Formulation Development Outsourcing Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 69 Key country dynamics
Figure 70 Denmark Formulation Development Outsourcing Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 71 Key country dynamics
Figure 72 Norway Formulation Development Outsourcing Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 73 Asia Pacific Formulation Development Outsourcing Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 74 Key country dynamics
Figure 75 China Formulation Development Outsourcing Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 76 Key country dynamics
Figure 77 India Formulation Development Outsourcing Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 78 Key country dynamics
Figure 79 Japan Formulation Development Outsourcing Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 80 Key country dynamics
Figure 81 Australia Formulation Development Outsourcing Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 82 Key country dynamics
Figure 83 South Korea Formulation Development Outsourcing Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 84 Key country dynamics
Figure 85 Indonesia Formulation Development Outsourcing Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 86 Key country dynamics
Figure 87 Malaysia Formulation Development Outsourcing Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 88 Key country dynamics
Figure 89 Singapore Formulation Development Outsourcing Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 90 Key country dynamics
Figure 91 Thailand Formulation Development Outsourcing Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 92 Key country dynamics
Figure 93 Taiwan Formulation Development Outsourcing Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 94 Latin America Formulation Development Outsourcing Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 95 Key country dynamics
Figure 96 Brazil Formulation Development Outsourcing Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 97 Key country dynamics
Figure 98 Argentina Formulation Development Outsourcing Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 99 Key country dynamics
Figure 100 Colombia Formulation Development Outsourcing Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 101 Key country dynamics
Figure 102 Chile Formulation Development Outsourcing Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 103 MEA Formulation Development Outsourcing Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 104 Key country dynamics
Figure 105 South Africa Formulation Development Outsourcing Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 106 Key country dynamics
Figure 107 Saudi Arabia Formulation Development Outsourcing Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 108 Key country dynamics
Figure 109 UAE Formulation Development Outsourcing Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 110 Key country dynamics
Figure 111 Egypt Formulation Development Outsourcing Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 112 Key country dynamics
Figure 113 Israel Formulation Development Outsourcing Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 114 Key country dynamics
Figure 115 Kuwait Formulation Development Outsourcing Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 116 Key company categorization
Figure 117 Service heat map analysis
Figure 118 Strategic framework
Figure 2 Information procurement
Figure 3 Primary research pattern
Figure 4 Market research approaches
Figure 5 Market formulation & validation
Figure 6 Commodity flow analysis
Figure 7 Value-chain-based sizing & forecasting
Figure 8 QFD model sizing & forecasting
Figure 9 Bottom-up approach
Figure 10 Market snapshot
Figure 11 Segment snapshot 1
Figure 12 Segment snapshot 2
Figure 13 Competitive landscape snapshot
Figure 14 Parent market outlook, 2024 (USD Billion)
Figure 15 Ancillary market outlook, 2024 (USD Billion)
Figure 16 Formulation Development Outsourcing Market dynamics
Figure 17 Porter’s five forces analysis
Figure 18 PESTEL analysis
Figure 19 Formulation Development Outsourcing Market: Service outlook and key takeaways
Figure 20 Formulation Development Outsourcing Market: Service movement analysis
Figure 21 Preformulation Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 22 Formulation Development Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 23 Formulation Development Outsourcing Market: Formulation outlook and key takeaways
Figure 24 Formulation Development Outsourcing Market: Formulation movement analysis
Figure 25 Oral Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 26 Injectable Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 27 Topical Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 28 Others Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 29 Formulation Development Outsourcing Market: Therapeutic Area outlook and key takeaways
Figure 30 Formulation Development Outsourcing Market: Therapeutic Area Movement Analysis
Figure 31 Oncology Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 32 Infectious Disease Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 33 Neurology Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 34 Hematology Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 35 Respiratory Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 36 Cardiovascular Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 37 Dermatology Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 38 Others Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 39 Formulation Development Outsourcing Market: End Use outlook and key takeaways
Figure 40 Formulation Development Outsourcing Market: End Use movement analysis
Figure 41 Pharmaceutical and Biopharmaceutical Companies Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 42 Government and Academic Institutes Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 43 Others Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 44 Regional Marketplace: Key Takeaways
Figure 45 North America Formulation Development Outsourcing Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 46 Key country dynamics
Figure 47 U.S. Formulation Development Outsourcing Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 48 Key country dynamics
Figure 49 Canada Formulation Development Outsourcing Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 50 Key country dynamics
Figure 51 Mexico Formulation Development Outsourcing Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 52 Europe Formulation Development Outsourcing Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 53 Key country dynamics
Figure 54 UK Formulation Development Outsourcing Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 55 Key country dynamics
Figure 56 Germany Formulation Development Outsourcing Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 57 Key country dynamics
Figure 58 France Formulation Development Outsourcing Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 59 Key country dynamics
Figure 60 Italy Formulation Development Outsourcing Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 61 Key country dynamics
Figure 62 Spain Formulation Development Outsourcing Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 63 Key country dynamics
Figure 64 Netherlands Formulation Development Outsourcing Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 65 Key country dynamics
Figure 66 Switzerland Formulation Development Outsourcing Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 67 Key country dynamics
Figure 68 Sweden Formulation Development Outsourcing Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 69 Key country dynamics
Figure 70 Denmark Formulation Development Outsourcing Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 71 Key country dynamics
Figure 72 Norway Formulation Development Outsourcing Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 73 Asia Pacific Formulation Development Outsourcing Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 74 Key country dynamics
Figure 75 China Formulation Development Outsourcing Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 76 Key country dynamics
Figure 77 India Formulation Development Outsourcing Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 78 Key country dynamics
Figure 79 Japan Formulation Development Outsourcing Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 80 Key country dynamics
Figure 81 Australia Formulation Development Outsourcing Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 82 Key country dynamics
Figure 83 South Korea Formulation Development Outsourcing Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 84 Key country dynamics
Figure 85 Indonesia Formulation Development Outsourcing Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 86 Key country dynamics
Figure 87 Malaysia Formulation Development Outsourcing Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 88 Key country dynamics
Figure 89 Singapore Formulation Development Outsourcing Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 90 Key country dynamics
Figure 91 Thailand Formulation Development Outsourcing Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 92 Key country dynamics
Figure 93 Taiwan Formulation Development Outsourcing Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 94 Latin America Formulation Development Outsourcing Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 95 Key country dynamics
Figure 96 Brazil Formulation Development Outsourcing Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 97 Key country dynamics
Figure 98 Argentina Formulation Development Outsourcing Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 99 Key country dynamics
Figure 100 Colombia Formulation Development Outsourcing Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 101 Key country dynamics
Figure 102 Chile Formulation Development Outsourcing Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 103 MEA Formulation Development Outsourcing Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 104 Key country dynamics
Figure 105 South Africa Formulation Development Outsourcing Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 106 Key country dynamics
Figure 107 Saudi Arabia Formulation Development Outsourcing Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 108 Key country dynamics
Figure 109 UAE Formulation Development Outsourcing Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 110 Key country dynamics
Figure 111 Egypt Formulation Development Outsourcing Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 112 Key country dynamics
Figure 113 Israel Formulation Development Outsourcing Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 114 Key country dynamics
Figure 115 Kuwait Formulation Development Outsourcing Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 116 Key company categorization
Figure 117 Service heat map analysis
Figure 118 Strategic framework
Companies Mentioned
The companies profiled in this Formulation Development Outsourcing market report include:- SGS S.A.
- Intertek Group plc
- Recipharm
- Lonza
- Charles River Laboratories International, Inc.
- Eurofins Scientific SE
- Element
- Labcorp
- Thermo Fisher Scientific, Inc.
- Catalent Inc.
Methodology
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 120 |
| Published | April 2025 |
| Forecast Period | 2024 - 2030 |
| Estimated Market Value ( USD | $ 37.27 Billion |
| Forecasted Market Value ( USD | $ 60.66 Billion |
| Compound Annual Growth Rate | 8.6% |
| Regions Covered | Global |
| No. of Companies Mentioned | 11 |
